# MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/mek-inhibitors-for-neurofibromatosis-type-1-manifestations-clinical-evidence-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Peter de Blank,Andrea M. Gross,Srivandana Akshintala,Jaishri O. Blakeley,Gideon Bollag,Ashley Cannon,Eva Dombi,Jason Fangusaro,Bruce D. Gelb,Darren Hargrave,AeRang Kim,Laura J. Klesse,Mignon L. Loh,Staci Martin,Christopher L. Moertel,Roger J. Packer,Jonathan M. Payne,Katherine A. Rauen,Jonathan J. Rios,Nathan Robison,Elizabeth K. Schorry,Kevin Shannon,David A. Stevenson,Elliot Stieglitz,Nicole J. Ullrich,Karin S. Walsh,Brian Weiss,Pamela L. Wolters,Kaleb Yohay,Marielle E. Yohe,Brigitte C. Widemann,Michael J. Fisher |
| Citations | 102 |
| DOI | 10.1093/neuonc/noac165 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/neuro-oncology/advance-article-pdf/doi/10.1093/neuonc/noac165/45048084/noac165.pdf |
| OpenAlex ID | https://openalex.org/W4283827625 |
| PMID | 35788692 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Andrea M. Gross](https://scholariq.org/researchers/andrea-m-gross/)

## Paper primary topic

- [Neurofibromatosis and Schwannoma Cases](https://scholariq.org/topics/neurofibromatosis-and-schwannoma-cases/)

## Paper topics

- [Neurofibromatosis and Schwannoma Cases](https://scholariq.org/topics/neurofibromatosis-and-schwannoma-cases/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Meningioma and schwannoma management](https://scholariq.org/topics/meningioma-and-schwannoma-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.